4//SEC Filing
Woodrow Adam 4
Accession 0000904454-21-000622
CIK 0001178711other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 7:11 PM ET
Size
7.0 KB
Accession
0000904454-21-000622
Insider Transaction Report
Form 4
Woodrow Adam
VP & Chief Commercial Officer
Transactions
- Award
Common Stock
2021-08-16+37,500→ 512,296 total - Sale
Common Stock
2021-08-17$5.12/sh−10,975$56,192→ 501,321 total
Footnotes (3)
- [F1]Represents performance-based restricted stock units ("PRSUs") granted on July 31, 2019 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan that vested on August 16, 2021.
- [F2]Sale of shares to cover personal income tax obligations upon vesting of PRSUs, pursuant to Rule 10b5-1 trading plan.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $5.02 to $5.22. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3 to this Form 4.
Documents
Issuer
Paratek Pharmaceuticals, Inc.
CIK 0001178711
Entity typeother
Related Parties
1- filerCIK 0001639647
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 7:11 PM ET
- Size
- 7.0 KB